HOME >> BIOLOGY >> NEWS
As harmful as osteoporosis but less well known - New research better explains sarcopenia

nction.

Conclusions
This study provides evidence that higher plasma IL-6 levels and lower plasma IGF-I levels are associated with lower muscle strength and power. However, the reciprocal relationship between IL-6 and IGF-I in their joint effect on muscle function is more complex than previously understood. The role of IL-6 in the development of disability in older persons has been documented widely. Elevated plasma IL-6 levels are associated with high mortality in the elderly, and higher plasma IL-6 levels are often found in older persons who are disabled in activities of daily living. It has been proposed that the high risk of disability associated with high IL-6 serum levels is explained by the catabolic effect of IL-6 on muscle, which results in accelerated sarcopenia. However, the true effect of IL-6 on muscle has not been investigated fully. IL-6 plays a central role in the inflammatory response. In addition to its multiple effects at inflammation sites, IL-6 also induces the synthesis of the hepatic acute phase inflammation proteins, such as C-reactive protein, haptoglobin, and fibrinogen, while inhibiting the synthesis of others, such as IGF-I.

This study also explained a multifaceted relationship between plasma IL-6 and IGF-I that conditions the effect of these two mediators on muscle function. Based on the findings, and the literature, and in accordance with some literature, it is reasonable to hypothesize that a high level of inflammation, documented by high plasma IL-6 levels, might negatively affect muscle function through three different mechanisms as follows: 1) IL-6 directly affects muscle strength; 2) IL-6 inhibits the synthesis of IGF-I; and 3) IL-6 blocks the effect of IGF-I. These possibilities, although not definitively proved, are supported by the following findings of our study. 1) IL-6 was an independent predictor of handgrip and muscle power, especially in subjects with the highest level of plasma IL-6 levels, suggesti
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
2-Apr-2003


Page: 1 2 3 4 5 6

Related biology news :

1. Excess thyroid hormone harmful to fetus
2. Figs may inhibit growth and survival of harmful microbes in food
3. Study of Cape Cod Seashore finds off-road vehicles harmful to beach fauna
4. Is a single bout of exercise helpful or harmful in getting a good nights sleep?
5. Preventative bed rest during pregnancy may be more harmful than helpful
6. Kidney injurys harmful effects on bones blocked in mice
7. Gene may protect against heart disease rather than be harmful as previously thought
8. Breastfeeding may compensate for harmful effects of smoking during pregnancy
9. Female hormones found to protect against harmful effects of fructose
10. URI oceanographers study effects of harmful blooms and red tides on Narragansett Bay
11. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... ... ... The ASGCT Clinical Trials Finder is a customizable search engine ... Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable listings anywhere in ... in the development of the ASGCT Clinical Trials Finder reviewed the relevance ...
(Date:5/16/2019)... ... May 16, 2019 , ... SFC Fluidics, Inc. ... the Industry Development and Discovery Partnership that was awarded to SFC Fluidics in 2018 ... integrated pod artificial pancreas (AP) system for people with type 1 diabetes (T1D). By ...
(Date:5/14/2019)... ... May 13, 2019 , ... NRD, LLC is ... Boston on May 15-16, 2019, the largest medical technology event in the Northeast ... and embedded systems product organizations. , They will be displaying their latest technologies, ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... Calif. (PRWEB) , ... April 09, 2019 , ... ... services firm focused on increasing the capacity of life sciences organizations to accelerate ... Cloud Assurance platform in the past 12 months. , USDM’s ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities , an affiliate ... investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a ... female hypoactive sexual dysfunction disorder and is ready to begin phase 2b trials. In ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
(Date:3/23/2019)... ... 2019 , ... uBiome has awarded microbiome research support in ... Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. Kingsley C. Anukam, ... Medical Laboratory Sciences and Deputy Provost, College of Health Sciences. The study hopes ...
Breaking Biology Technology:
Cached News: